Mutation patterns of the reverse transcriptase and protease genes in human immunodeficiency virus type 1-infected patients undergoing combination therapy:: Survey of 787 sequences

被引:98
作者
Yahi, N
Tamalet, C
Tourrès, C
Tivoli, N
Ariasi, F
Volot, F
Gastaut, JA
Gallais, H
Moreau, J
Fantini, J [1 ]
机构
[1] Fac Sci St Jerome, ESA CNRS 6033, Lab Biochim & Biol Nutr, F-13397 Marseille 20, France
[2] CHRU Timone, UF SIDA, Virol Lab, F-13005 Marseille, France
[3] CHRU Timone, Serv Informat Med, F-13005 Marseille, France
[4] CISIH, F-13005 Marseille, France
关键词
D O I
10.1128/JCM.37.12.4099-4106.1999
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The aim of the present study was to evaluate the resistance-associated mutations in 302 human immunodeficiency virus type 1 (HIV-l)-infected patients receiving combination therapy and monitored in Marseille, France, hospitals from January 1997 to June 1998, In the reverse transcriptase (RT) gene, the most frequent mutations were found at codons 215 (53%), 41 (34%), and 67, 70, 184, and 210 (>20%), One deletion and two insertions in the beta 3-beta 4 hairpin loop of the finger subdomain (codon 69) were detected. Interesting associations and/or exclusions of specific mutations were observed, In 96% of RT genes, a mutation at codon 70 (most frequently, K70R) was associated with a wild-type genotype at position 210 (P < 10(-5)). Similarly, a mutation at codon 210 (most frequently, L210W) was generally associated with mutations at codons 41 (92%) and 215 (96%) but not at codon 219 (16%) or codon 70 (4%) (P < 10(-5)). In the protease gene, the most prevalent mutations were at codons 63 (84%), followed by codons 10, 36, 71, 77, and 93 (ca. 20%), As for RT, pairwise associations of mutations were observed. Analysis of the mutation patterns for patients with undetectable HIV-1 loads revealed a high proportion (65%) of wild-type RT genotypes but only 18% wild-type protease genotypes, For patients with high viral loads (>100,000 copies/ml), more than 50% of the RT and protease genes displayed three or more mutations. The significant correlation between the level of viremia in plasma and the number of resistance mutations in the protease (P = 0.007) and RT (P = 0.00078) genes strengthens the importance of defining the genotype of the predominant HIV-I quasispecies before initiating antiretroviral therapy.
引用
收藏
页码:4099 / 4106
页数:8
相关论文
共 29 条
[1]  
BEARD WA, 1958, HIV PRACTICAL APPROA, V2, P15
[2]   ORDERED APPEARANCE OF ZIDOVUDINE RESISTANCE MUTATIONS DURING TREATMENT OF 18 HUMAN IMMUNODEFICIENCY VIRUS-POSITIVE SUBJECTS [J].
BOUCHER, CAB ;
OSULLIVAN, E ;
MULDER, JW ;
RAMAUTARSING, C ;
KELLAM, P ;
DARBY, G ;
LANGE, JMA ;
GOUDSMIT, J ;
LARDER, BA .
JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (01) :105-110
[3]   Associations between amino acids in the evolution of HIV type 1 protease sequences under indinavir therapy [J].
Brown, AJL ;
Korber, BT ;
Condra, JH .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1999, 15 (03) :247-253
[4]   Evolution of zidovudine resistance-associated genotypes in human immunodeficiency virus type 1-infected patients [J].
Cleland, A ;
Watson, HG ;
Robertson, P ;
Ludlam, CA ;
Brown, AJL .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1996, 12 (01) :6-18
[5]   HIV POPULATION-DYNAMICS IN-VIVO - IMPLICATIONS FOR GENETIC-VARIATION, PATHOGENESIS, AND THERAPY [J].
COFFIN, JM .
SCIENCE, 1995, 267 (5197) :483-489
[6]   pol gene diversity of five human immunodeficiency virus type 1 subtypes: Evidence for naturally occurring mutations that contribute to drug resistance, limited recombination patterns, and common ancestry for subtypes B and D [J].
Cornelissen, M ;
vandenBurg, R ;
Zorgdrager, F ;
Lukashov, V ;
Goudsmit, J .
JOURNAL OF VIROLOGY, 1997, 71 (09) :6348-6358
[7]   RNA virus mutations and fitness for survival [J].
Domingo, E ;
Holland, JJ .
ANNUAL REVIEW OF MICROBIOLOGY, 1997, 51 :151-178
[8]   Antiretroviral drug resistance testing in adults with HIV infection -: Implications for clinical management [J].
Hirsch, MS ;
Conway, B ;
D'Aquila, RT ;
Johnson, VA ;
Brun-Vézinet, F ;
Clotet, B ;
Demeter, LM ;
Hammer, SM ;
Jacobsen, DM ;
Kuritzkes, DR ;
Loveday, C ;
Mellors, JW ;
Vella, S ;
Richman, DD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (24) :1984-1991
[9]   An in vivo mutation from leucine to tryptophan at position 210 in human immunodeficiency virus type 1 reverse transcriptase contributes to high-level resistance to 3'-azido-3'-deoxythymidine [J].
Hooker, DJ ;
Tachedjian, G ;
Solomon, AE ;
Gurusinghe, AD ;
Land, S ;
Birch, C ;
Anderson, JL ;
Roy, BM ;
Arnold, E ;
Deacon, NJ .
JOURNAL OF VIROLOGY, 1996, 70 (11) :8010-8018
[10]   Higher fidelity of RNA-dependent DNA mispair extension by M184V drug-resistant than wild-type reverse transcriptase of human immunodeficiency virus type 1 [J].
Hsu, ML ;
Inouye, P ;
Rezende, L ;
Richard, N ;
Li, Z ;
Prasad, VR ;
Wainberg, MA .
NUCLEIC ACIDS RESEARCH, 1997, 25 (22) :4532-4536